IP Library Granted Patent US 8,507,200
Granted Patent B2
US 8,507,200 · App. 12/526,560 · Granted Aug 13, 2013

Particles for detecting intracellular targets

Inventors: Chad A. Mirkin (Wilmette, IL); Dwight Seferos (Toronto, CA); David A. Giljohann (Chicago, IL)
Assignee: Northwestern University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,507,200
App. No.
12/526,560
Granted
Aug 13, 2013
Kind
B2
Abstract

Methods describing the use of nanoparticles modified with binding moieties are provided.

Claims (9)

1. A method of determining the intracellular concentration of a target polynucleotide comprising the step of contacting the target polynucleotide with a nanoparticle under conditions that allow association of the target polynucleotide with the nanoparticle, said nanoparticle comprising a binding moiety polynucleotide specific for said target polynucleotide, said binding moiety polynucleotide labeled with a marker, wherein the association of the target polynucleotide and the nanoparticle results in detectable change in the marker, wherein the change in the detectable marker is proportional to the intracellular concentration of said target polynucleotide, said binding moiety polynucleotide is covalently attached to said nanoparticle and said marker is a label attached to a polynucleotide hybridized to said binding moiety polynucleotide, wherein association of said binding moiety polynucleotide with said target polynucleotide releases said hybridized polynucleotide and said marker is detectable after release.

2. The method of claim 1 wherein the binding moiety polynucleotide is DNA.

3. The method of claim 1 wherein the binding moiety polynucleotide is RNA.

4. The method of claim 1 wherein said label attached to said polynucleotide is quenched when said polynucleotide with said label is hybridized to said binding moiety polynucleotide.

5. The method of claim 1 wherein said binding moiety polynucleotide comprises a marker which is a detectable label, wherein said marker is detectable only when said binding moiety polynucleotide is associated with the target polynucleotide.

6. The method of claim 5 wherein said marker is quenched when said binding moiety polynucleotide is not associated with said target polynucleotide.

7. The method of claim 1 wherein said nanoparticle comprises a multiplicity of binding moiety polynucleotides.

8. The method of claim 7 wherein the binding moiety polynucleotides specifically associate with one target polynucleotide.

9. The method of claim 7 wherein the binding moiety polynucleotides specifically associate with more than one target polynucleotide.

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 26, 2021
From: NORTHWESTERN UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR; NATIONAL SCIENCE FOUNDATION; MRDC
Reel/Frame 058477/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2009
From: MIRKIN, CHAD A.; SEFEROS, DWIGHT; GILJOHANN, DAVID A.
To: NORTHWESTERN UNIVERSITY
Reel/Frame 023217/0224 →
CONFIRMATORY LICENSE Recorded Sep 4, 2009
From: NORTHWESTERN UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023194/0546 →
Continuity (3)
Provisional Application 60900648 · Feb 9, 2007
Provisional Application 60956205 · Aug 16, 2007
Related Publication 20100129808A1 · May 27, 2010